🇺🇸 Pharmacological cardioversion with Refralon in United States

Pharmacological cardioversion with Refralon (Pharmacological cardioversion with Refralon) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pharmacological cardioversion with Refralon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pharmacological cardioversion with Refralon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pharmacological cardioversion with Refralon in United States?

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.